| Literature DB >> 9148333 |
A V Naghettini1, R R Daher, R M Martin, J Doles, B Vanderborght, C F Yoshida, C Rouzere.
Abstract
The patients were 173, aged 10 to 70 years old. An Elisa II test was undertaken and 61 to 173 (35.3%) had positive test; when INNO-LIA test was made, soropositivity was 26% (44/173). Patients with anti-VHC antibodies have been kept on hemodialysis treatment for periods longer than negatives (p < 0.05). Neither drugs users, blood transfusions, sexual and aminotransferase activity were significantly correlated with the infection. There is an elevated prevalence of anti-VHC antibodies among chronic hemodialysis patients which seems to be related to the time that patients are on dialysis treatment.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9148333 DOI： 10.1590/s0037-86821997000200005
Source DB: PubMed Journal: Rev Soc Bras Med Trop ISSN： 0037-8682 Impact factor: 1.581